PSNL (Personalis) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 24, 2026)


PSNL Personalis Inc PSNL
59 GF Score
Price $11.36
GF Value $2.07
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Personalis Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Personalis's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

PSNL vs CDNA, OPK, NEO: Margin of Safety % (DCF FCF Based) Comparison

For the Diagnostics & Research subindustry, Personalis's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Personalis Margin of Safety % (DCF FCF Based) vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Personalis's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Personalis's Margin of Safety % (DCF FCF Based) falls into.


PSNL
59GF Score
Personalis Inc PSNL
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Personalis (PSNL) Overvalued in 2026?

Based on GuruFocus' analysis, Personalis stock appears to be overvalued. The current stock price of $11.36 is trading 448.8% above its estimated GF Value™ of $2.07. GuruFocus considers Personalis to be Significantly Overvalued.

Key valuation signals for PSNL:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $2.07 vs. price of $11.36 (448.8% above fair value)
  • GF Score™: 59/100 with 6 warning signs

No single metric tells the full story. See the PSNL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Personalis Business Description

Other Exchanges 04X:Germany
Address 6600 Dumbarton Circle, Fremont, CA, USA, 94555
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
59GF Score

Get the complete analysis for PSNL

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.36
Price
$2.07
GF Value